Lotte Biologics Co Ltd - Strategic SWOT Analysis Review

Lotte Biologics Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Report Scope

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - The analyst’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Lotte Biologics Co Ltd (Lotte Biologics), a subsidiary of Lotte Corp, is a contract development and manufacturing organization (CDMO). It offers various services encompassing contract development, contract manufacturing, and analytical testing services for biologics and Antibody-Drug Conjugates (ADCs). The company's services include cell line development, product launches, scale-down process verification, technology transfers, cGMP manufacturing for clinical and commercial drug substance, formulation development, aseptic filling, labeling and packaging, incoming raw materials testing, in-process testing, finished product testing, stability testing, bioconjugation development, bioconjugation manufacturing (non-GMP/cGMP ADC DS Manufacturing), analysis for ADCs. It operates a bio campus in Syracuse, New York; and a sales office in Boston, the US. Lotte Biologics is headquartered in Seoul, South Korea.

Lotte Biologics Co Ltd Key Recent Developments

• Apr 02, 2026: LOTTE HOLDINGS Healthcare and Biopharmaceutical CVC Invests in Rakuten Medical, Inc.
• Mar 17, 2026: LOTTE Biologics Implements ValGenesis E-Logbook to Modernize QC Operations
• Mar 09, 2026: LOTTE Biologics to Participate in DCAT Week 2026 in New York
• Mar 09, 2026: Lotte Biologics to Participate in DCAT Week 2026 in New York to Explore Global Partnership Opportunities

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.